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Abstract: The aim of this study was to evaluate the effects of single oral doses of D-005 (a lipid extract obtained from the fruit oil of 
Acrocomia crispa) on LPS-induced acute lung injury (ALI) in mice. D-005 batch composition was: lauric (35.8%), oleic (28.4%), myristic 
(14.2%), palmitic (8.9%), stearic (3.3%), capric (1.9%), caprylic (1.2%), and palmitoleic (0.05%) acids, for a total content of fatty acids of 
93.7%. D-005 (200 mg/kg) significantly reduced lung edema (LE) (≈ 28% inhibition) and Lung Weight/Body Weight ratio (LW/BW) 
(75.8% inhibition). D-005 (25, 50, 100 and 200 mg/kg) produced a significant reduction of Histological score (59.9, 56.1, 53.5 and 73.3% 
inhibition, respectively). Dexamethasone, as the reference drug, was effective in this experimental model. In conclusion, pretreatment with 
single oral doses of D-005 significantly prevented the LPS-induced ALI in mice. 
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Resumen: El objetivo de este estudio fue evaluar los efectos de dosis orales únicas de D-005 (extracto lipídico obtenido del aceite de frutos 
de Acrocomia crispa) sobre el daño pulmonar agudo (DPA) inducido por LPS en ratones. La composición del lote de D-005 fue: ácido 
láurico (35.8%), oleico (28.4%), mirístico (14.2%), palmítico (8.9%), esteárico (3.3%), cáprico (1.9%), caprílico (1.2%) y palmitoleico 
(0.05%), con un contenido total de ácidos grasos de 93.7%. D-005 (200 mg/kg) redujo significativamente el edema pulmonar (EP) (≈ 28% 
de inhibición) y la relación peso pulmón/peso corporal (PP/PC) (75.8% de inhibición). D-005 (25, 50, 100 y 200 mg/kg) produjo una 
reducción significativa de la puntuación histológica (59.9, 56.1, 53.5 y 73.3% de inhibición, respectivamente). La dexametasona, fármaco de 
referencia, fue efectiva en este modelo experimental. En conclusión, el pretratamiento con dosis orales únicas de D-005 previno 
significativamente el DPA inducido por LPS en ratones. 
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INTRODUCTION 
The acute respiratory distress syndrome (ARDS) 
was firstly described in 1967 (Ashbaugh et al., 
1967) in patients with acute attacks of tachypnea 
and hypoxia, being considered as a severe 
particular case of acute lung injury (ALI) (Bernard 
et al., 1994; Ranieri et al., 2012). 
ARDS/ALI causes could be from a 
multifactorial origin and generally are associated to 
diffuse alveolar damage characterized by clinical 
symptoms of dyspnea, arterial hypoxaemia and 
bilateral pulmonary infiltrates in absence of clinical 
evidence of left atrial hypertension. Both of them 
are responsible for thousands of adult and pediatric 
deaths annually worldwide, showing a significant 
mortality rate (30 - 60% of all reported cases) 
(Singh et al., 2014), while the most common 
initiating event of ALI/ARDS involved: gastric acid 
aspiration, pneumonia, pulmonary contusion, 
sepsis, shock, trauma, multiple transfusions, 
pancreatitis, etc (Matute et al., 2008; Travieso & 
Blanco, 2009). 
Inflammation is an important etiological 
factor in the development and progression of this 
pathology. An acute inflammatory response in the 
airways causes damage to the epithelium and 
pulmonary endothelium, with the subsequent 
release of oxidizing substances and proteases. On 
the other hand, arachidonic acid derivatives such as 
prostaglandins, thromboxanes and leukotrienes, are 
implicated as pro-inflammatory mediators of ALI. 
Significant modifications in the levels of 
thromboxanes in tissues, as well as circulating 
prostacyclines promote the formation of edema and 
changes in pulmonary perfusion due to the increase 
in the synthesis of mediators of COX-2 (Min et al. 
2012; Howden et al. 2012; Bulmuş et al. 2013).  
Up to the present there is no evidence of 
effective pharmacological therapies to treat 
ALI/ARDS, which justifies the search for new 
pharmacotherapeutic strategies as a current issue. 
Emerging therapies currently under investigation to 
prevent or treat ALI will provide further strategies 
to reduce these mortality rates, making a 
noteworthy emphasis on the natural products. In 
these sense, medicinal plants play an essential role 
as an important source of pharmacological active 
metabolites. 
The palm family Arecaceae is a wide group 
comprising approximately 217 genera and 2,500 
arboreal species to be found throughout equatorial, 
tropical, and subtropical areas of the world 
(Sosnowska and Henrik, 2009). Palm fruits are an 
important oleaginous resource for the development 
of the pharmaceutical and cosmetic industries. The 
species Elaeis guineensis Jacq, Cocos nucifera L. 
and Serenoa repens L. are widely used for these 
purposes (Rodríguez et al. 2007; González. and 
Bravo, 2017; Ghorbanpour et al., 2017). In Cuba 
this family is represented by a great diversity of 
species (Muñiz & Borhide, 1982), Roystonea regia 
(Cuban royal palm) being a specie widely studied 
for medicinal uses as antioxidant (López et al., 
2009; Rodríguez et al., 2010; Oyarzábal et al., 
2011; González et al., 2013), antiinflamatory 
(Menéndez et al., 2006; Ravelo et al., 2011, 
González et al., 2013) and in benign prostatic 
hyperplasia (Pérez et al., 2010; Oyarzábal et al., 
2013; Guzmán et al., 2013; Oyarzabal et al., 2015), 
while other species such as Acrocomia crispa 
(Cuban belly palm), another Cuban endemic palm, 
with medicinal potentialities has not been 
sufficiently studied nor employed industrially 
before. Up to the present there is no documentation 
of its use in folk medicine.  
D-005, a lipid extract obtained from the 
fruit oil of A. crispa, contains a reproducible 
mixture of free fatty acids, mainly lauric, oleic, 
myristic, and palmitic acids; while stearic, capric, 
caprylic and palmitoleic acids are present in lower 
concentrations. (Sierra et al., 2015) Previous 
studies showed that some of these fatty acids, such 
as myristic, steraic, palmitic, oleic, and several oily 
extracts containing these fatty acids inhibited 
cyclooxygenase (COX) and lipooxygenase (LOX) 
activities in vitro (Chan et al., 1996; Zhang et al., 
2002; Henry et al., 2002; Menéndez et al., 2007). 
In consonance with this data, a more recent 
study demonstrated that D-005 inhibited COX-2 
and 5-LOX enzyme activities, with highest affinity 
for COX-2. The dual inhibition of COX-2 and 5-
LOX suggested that D-005 could produce anti-
inflammatory effects (Pérez et al., 2017). 
Taking into account the primary role played 
by the COX-2 and 5-LOX enzymes in the 
pulmonary inflammatory process involved in the 
development and progression of ALI (Min et al. 
2012; Howden et al. 2012; Bulmuş et al. 2013), it is 
logical to assume that D-005 could provide a 
protective effect on ALI due to its anti-
inflammatory profile dual (Pérez et al., 2017). In 
addition, ALI is one of the most serious health 
problems due to its high mortality rate (Singh et al., 
2014), and until now is an orphan disease of 
effective pharmacological therapies, that is, without 
a cure. So, it becomes justifies characterize the lipid 
extract of fruits of A. crispa and evaluate its 
relevance in the context of acute lung injury. 
Several experimental models and different 
species of animals in the preclinical evaluation of 
some drugs have been used extensively to 
reproduce the essential manifestation and the most 
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important events of ALI. However, ALI induced by 
lipopolysaccharide (LPS) in mice is a classical 
model being widely developed by the researchers 
worldwide (Matute et al., 2008; Mena et al., 2016). 
In light of these issues, this study was 
carried out to evaluate the effects of D-005 on LPS-
induced ALI in mice. 
 
MATERIALS AND METHODS 
Extract preparation 
Ripe fruits of A. crispa were collected and 
authenticated (No. 1982-1031) in the National 
Botanic Garden (Havana, Cuba). Fruits were dried 
under shade in a well-ventilated area, powdered 
with a hammer mill at 2.36 mm, and extracted with 
n-hexane at room temperature (three extractions of 
24 h). Solvent was removed at 60°C under vacuum, 
in a Büchi rotary evaporator, and the obtained oil 
was saponified at reflux with a hydro alcoholic 
potassium hydroxide solution (0.5 mol/L). 
Afterwards, the fatty acids were released with HCl 
(10%) until pH 1-2, and the organic phase was 
washed with water and dried under vacuum at 
110°C. The product obtained was the D-005 batch 
used in this study.  
 
Sample preparation for chromatographic analysis 
D-005 batch composition was assessed by a 
validated specific gas chromatographic method. 
Fatty acids were prepared for analysis as fatty acid 
methyl esters using a validated one-step extraction-
transesterification method (Rodriguez et al., 2009). 
Approximately 100 mg of D-005 were placed into a 
15 mL tube with Teflon-lined screw cap. One 
millilitre of methanol containing 1 mg of the 
internal standard tridecanoic acid (Sigma-Aldrich, 
St. Louis, MO, USA), 3 mL of freshly prepared 
acetyl chloride (10%) in methanol and 5 ml hexane 
were added. The tube was capped, shaken, and 
incubated at 85 °C for 30 min in a dried thermostat, 
with occasional shaking. After allowing the tube to 
cool to room temperature, 3 mL of sodium 
hydroxide (2 mol/L) were added, the tube was 
shaken in a horizontal shaker for 15 min, and then it 
was let to stand around two minutes until phase 
separation. One mL of the supernatant was 
carefully transferred to a vial, 1 mL hexane was 
added, the vial was capped, shaken for 
homogenizing, and 1 L was taken for 
chromatographic analysis. 
 
Fatty Acid Methyl Esters Gas Chromatography-
Flame Ionization Detector Analysis 
Prepared samples of the batch (n=3) were analysed 
for fatty acid methyl esters using an Agilent 
equipment model 7890A (Agilent Technologies, 
SA) with a BPX-5wide-bore capillary column (30 
m × 0.53 mm × df 1.5 μm, SGE, Australia). 
Injection port and detector temperatures were 
maintained at 320 °C. Hydrogen was used as the 
carrier gas at a flow rate of 8 mL/min. A 
temperature gradient was used with an initial oven 
temperature of 120 °C (2 min) that increased to 320 
°C at 10 °C/min. Fatty acid methyl esters were 
identified by their retention times using the FAME 
standard mix (Supelco, USA) and quantified using 
Agilent Chem Station software. 
 
Animals and Study protocol 
BALB/c male mice (18-20 g), from the Center for 
Laboratory Animals Production (CENPALAB, 
Habana, Cuba) were adapted for 7 days to 
controlled laboratory conditions: temperature (25 ± 
2 oC, 60 ± 5 % relative humidity and 12 hours’ 
light/dark cycles). Food (rodent pellets supplied by 
CENPALAB) and water were provided ad libitum. 
Animal handle was conducted according to the 
Cuban Code for the Use of Laboratory Animals and 
ethical principles for animal management No.39/04. 
The independent ethical board of the Center of 
Natural Products approved the use of animals and 
the study protocol. 
 
Substances Preparation, administration and 
dosage 
D-005, immediately before use was suspended in a 
vehicle (Tween 65/water, 2%) and Dexamethasone 
injectable (Dex) (Carlos J. Finlay laboratory, 
Havana, Cuba) was used as reference drug. LPS, 
inductor agent of ALI, (Escherichia coli serotype 
055: B5; Sigma Chemical Co., St. Louis, MO), was 
dissolved in 20 ml of saline solution (0.9%). 
After quarantine period, mice were 
randomly divided in eight groups (n=10). 
Experimental groups were as follows: a negative 
control group (Tween 65/water oral vehicle 
administration and 0.2 ml i.p saline solution) 
without damage induction and seven groups 
injected with LPS (20 mg/kg, i.p): Positive control 
(Tween 65/water vehicle), D-005 (5, 25, 50, 100, 
200 mg/kg) and Dex (20 mg/kg) group. Oral 
administration by gastric gavage of D-005 and Dex 
were started 60 min before the intra-peritoneal 
injection of saline or LPS (20 mg/kg). 
 
Mena et al.                                       Acrocomia crispa fruit lipid extract prevents acute lung injury in mice  
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/19 
 
Experimental Procedure 
One hour before D-005 or Dex administration, 
except the negative control group, animals were 
injected with LPS (20mg/kg, ip). Twenty-four 
hours later, anesthesia state was induced by 
thiopental sodium injection (40 mg/kg, ip) and 
animals were sacrificed by exsanguinations. 
Afterwards, lungs and tissue samples were 
collected to quantify the lung edema (LE) and lung 
weight/body weight ratio (LW/BW ratio) and to 
determine the histopathological changes, 
respectively. 
 
Determination of LW/BW ratio and lung edema 
Mice Body weight (BW) was determined in an 
analytical balance before the sacrifice, while, lung 
weight (LW) was immediately determined after to 
extraction. The LW/BW ratio was calculated taking 
into account the values of LW and BW. 
LE was determined according to the 
method described by He et al (He et al., 2014). We 
evaluated LPS-induced edema by measuring the 
content of lung water as follow: the left lung was 
weighed out in analytical balance to obtain the wet 
weight (WW) and then it was exposed to a 
temperature of 85°C for 48 h to determine dry 
weight (DW). 
The LE was expressed by the mathematical 
expression: LE = (WW – DW)/WW × 100%. 
 
Histological analysis 
The lungs were extracted and fixed in buffered 
formaldehyde solution (10%). After fixation, the 
lung tissue was sectioned sagittally and embedded 
in paraffin. The sections were stained with 
hematoxylin – eosin (HE). Histological analysis of 
lung damage was evaluated according to the 
following variables: neutrophil infiltration, 
haemorrhages, oedema, exudation, necrosis, 
congestion, atelectasis and alveolar thickening. The 
severity of lung injury was evaluated establishing a 
histological score according to the following 
criteria: No damage, 0; damage in 25% of the 
fields, 1; damage in 50% of the fields, 2; damage in 
75% of the fields, 3; diffuse damage, 4 (He et al., 
2014). 
 
Statistical Analysis 
Comparisons among groups were done by using the 
Kruskal-Wallis test and paired comparisons 
between treated and control groups were done by 
using Mann-Whitney U test. The level of statistical 
significance was set at =0.05. Data were 
processed with the Statistics Software for Windows 
(Release 6.1 Stat Soft Inc, Tulsa OK, USA).  
 
RESULTS 
Chemical analysis of D-005 batch 
D-005 fatty acid composition, analyzed by Gas 
Chromatography (Figure No. 1), was as follows 
(w/w, %): lauric (35.8%), oleic (28.4%), myristic 
(14.2%), palmitic (8.9%), stearic (3.3%), capric 
(1.9%), caprylic (1.2%), and palmitoleic (0.05%), 
for a total content of fatty acids of 93.7%. Other 
fatty acids were analyzed and quantified, but only 
the eight major fatty acids, are reported 
individually. The mean percent coefficient of 
variance between duplicates for total fatty acids 
was 0.8%. 
 
Biological effects of D-005 on LPS-injection 
induced ALI.  
Table No. 1 shows the effects of single oral 
administration of D-005 on LE and LW/BW ratio 
in mice with ALI induced by LPS. The i.p. 
injection with LPS produced a significant (p<0.01) 
increase of LE and LW/BW ratio in animals of 
positive control group compared to animals of 
negative control group. 
D-005 (5-200 mg/kg) reduced moderately 
(≈ 28% inhibition) the levels of LE, but only the 
doses of 200mg/kg, produced a significant 
reduction (p<0.05). Furthermore, D-005 decreased 
the LW/BW ratio, although only the effect of the 
highest dose (200 mg/kg) was marked (75.86% 
inhibition) and significant (p<0.05).  Dex (20 
mg/kg), reference drug, reduced marked (65.60% 
inhibition) and significantly (p<0.05) not only the 
LE but also the LW/BW ratio (58.62% inhibition). 
ALI induction by LPS caused a significant 
increase of the HS in the positive control group 
(p<0.001) compared to the negative control group. 
The Table No. 2 shows the effects of D-005 oral 
administration on histological score (HS) in mice 
with ALI induced by LPS. The lowest assayed dose 
(5 mg/kg) moderately, but not significantly, 
reduced the HS while doses of D-005 (25, 50, 100 
and 200 mg/kg) produced a significant (p<0.05) 
and marked inhibition (59.9, 56.1, 53.5 and 73.2%, 
respectively) of HS. Dex (20 mg/kg), reference 
drug, significantly (p<0.05) and markedly inhibited 
HS by 59.9%. 
Normal structure of lung tissues was 
observed in all negative control mice. The Figure 
No. 2A shows the lung tissue from an animal of the 
negative control group with a normal distribution of 
alveolar spaces, also a normal appearance of the 
squamous epithelium and capillaries without signs 
of inflammation. By the opposite, lung tissue of all 
positive controls displayed marked signs of ALI 
such as severe neutrophil infiltration and alveolar 
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thickening almost in 50-75% of the histological fields (Figure No. 2B). 
 
Figure No. 1 
Gas Chromatogram of D-005 showing majorly compounds from the total fatty acid  
composition by black arrows 
 
 
 
Table No. 1 
Effects of D-005 on LE and LW/BW ratio on LPS induced ALI in mice 
 
Groups 
 
LE [%] 
 
I [%] 
 
LW/BW 
 
I [%] 
Negative control (Vehicle)  
 
78,22 ± 1,08 ** - 0,60±0.08** - 
Positive control (Vehicle + LPS)  
 
83,86±1,08 - 0,89±0,05 - 
D-005 5 mg/kg + LPS  
 
81,81±0,92 36,3 0,78±0,42 37,9 
D-005 25 mg/kg + LPS  
 
82,24±0,77 28,7 0,78±0,43 37,9 
D-005 50 mg/kg + LPS  
 
82,63±0,91 21,8 0,76±0,03 44,8 
D-005 100 mg/kg + LPS  
 
82,56±0,92 23,0 0,76±0,04 44,8 
D-005 200 mg/kg + LPS  
 
82,25±0,46* 28,5 0,67±0,01* 75,8 
Dex 20 mg/kg + LPS 80,16±0,64* 65,6 0,72±0,04* 58,6 
 
I: inhibition, LPS: lipopolysaccharide, LE: lung edema, 
 LW: lung weight, BW: body weight, Dex: dexamethasone. 
* p<0.01; ** p <0.001. Comparisons with the positive LPS control (Mann Whitney U test). 
 
 
 
 
Oleic acid 
Lauric acid 
Myristic acid 
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Table No. 2 
Effects of D-005 on histological score on LPS induced ALI in mice. 
 
GROUPS 
 
HS 
 
I [%] 
Negative control (Vehicle) 
 
0,75±0,16*** - 
Positive control (Vehicle + LPS) 
 
2,62±0,74 - 
D-005 5 mg/kg + LPS  
 
1,87±0,29 40,1 
D-005 25 mg/kg + LPS  
 
1,50±0,18* 59,9 
D-005 50 mg/kg + LPS  
 
1,57±0,20* 56,1 
D-005 100 mg/kg + LPS  
 
1,62±0,18* 53,5 
D-005 200 mg/kg + LPS  
 
1,25±0,25** 73,2 
Dex 20 mg/kg + LPS  
 
1,50±0,32* 59,9 
I: inhibition, HS: histological score, Dex: dexamethasone. 
* p<0.01; ** p<0.001, ***p<0.001. Comparisons with the positive LPS control  
(Mann Whitney U test). 
 
Pretreatments with oral doses of D-005 (25-
200 mg/kg) ameliorated the pulmonary lesions, 
while the lowest dose assayed (5 mg/kg) achieved a 
slight but not significant inhibition of damage. The 
Figure No. 2C shows the principal findings 
observed in lung tissue of animals pretreated with 
this dose, being neutrophil infiltration and alveolar 
thickening, evident signs of ALI, while the doses of 
25 (Figure No. 2D) and 50 mg/kg (Figure No. 2E) 
only showed slight alterations characterized by a 
poorly neutrophil infiltration. 
In contrast, minor damages were found in 
lung tissues of animals pretreated with D-005 (100 
and 200 mg/kg). The Figure No. 2F and Figure No. 
2G illustrate a prominent attenuation of LPS-
induced pulmonary histopathologic findings 
observed in these D-005 treated groups. 
Dex was effective as reference drug 
achieving a marked and significant inhibition of 
ALI (Figure No. 2H). 
 
DISCUSSION 
Chromatographic analysis of this D-005 batch 
confirmed the presence of fatty acids between 8 and 
18 carbon atoms, which were identified by 
comparison of their relative retentions with 
commercial standards. The free fatty acids 
composition shows the lauric acid as the major 
component (35.8%), followed by oleic acid 
(28.4%), and myristic acid (14.2%). This result is 
similar to that obtained in a previous study (Sierra 
et al., 2015). Composition of D-005 differs from 
those obtained for the oily extracts of the hole fruits 
of S. repens (C18:1 = 43.29%, C12:0 = 26.60%, 
C14:0 = 11.49%) (Rodríguez et al., 2012) and R. 
regia (C18:1 = 48.50%, C12:0 = 23.30%, C14:0 = 
11.00%) (Rodríguez et al., 2007), which present 
higher proportions of oleic acid and lower 
proportions of lauric acid, although the saturated 
fatty acids predominate in the three extracts. In 
addition, it is important to highlight that total free 
fatty acids content in D-005 (> 90 %) is higher than 
those present in the oily extract of other Arecaceae 
as Serenoa repens (40.7- 80.7 %) (Habib, 2009). 
Arecaceae family is broadly distributed in 
Cuba and interestingly around 90% of palms 
species are endemic (Muñiz & Borhide, 1982). R. 
regia and A. crispa fruit extracts have a similar 
fatty acid composition (Rodríguez et al., 2007) and 
both species have been described as anti-
inflammatory (Ravelo et al. 2011, González et al., 
2013). The compounds mainly differ between 
species and are found in a variable percentage in oil 
extracts (Sierra et al., 2014). In accordance, it has 
been described that some oily extracts containing 
myristic, steraic, palmitic and oleic acid have an in 
vitro inhibitory effect on cyclooxygenase (COX) 
and lipooxygenase (LOX) activities, blockading an 
important pathway of pro-inflammatory precursors 
release. (Chan et al., 1996; Henry et al., 2002; 
Zhang et al., 2002; Menéndez et al., 2007; Pérez et 
al., 2017) 
 
a 
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Figure No. 2 
Lung sections, H&E, 40 X. A) Negative control. Normal appearance of alveolar walls without 
signs of inflammation; B) Positive control showing severe neutrophil infiltration and alveolar 
thickening; C) D-005 (5 mg/kg) showing neutrophil infiltration and alveolar thickening; D) D-
005 (25 mg/kg) and E) D-005 (50 mg/kg), showing poorly neutrophil infiltration. F) D-005 
(100 mg/kg), G) D-005 (200 mg/kg), H) Dexamethasone 200 mg/kg. In F, G and H a significant 
attenuation of LPS-induced pulmonary histopathologic changes are observed. Arrowheads: 
neutrophils, arrows: alveolar wall. The rectangles with dashed lines in B, C, D and E enclose 
regions that have been magnified to the right of each figure. Bars: 50 µm. 
H G 
A 
F 
D 
C 
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Intraperitoneal injection with LPS (20 mg/kg) 
induced ALI in mice. ALI was evidenced by a 
significant increase of LE, LW/BW ratio and the 
histological changes observed in positive control 
animals compared to negative control animals. In 
such regard, it is well known that LPS mechanism 
to induce ALI involves the LPS binding to specific 
proteins (P) in pulmonary endothelial cells to form 
a complex (LPS:P) which activates CD14/TLR4 
receptors on monocytes and macrophages 
promoting the inflammatory mediators release 
(Yang et al., 1998; Matute et al., 2008) mediated by 
the Nuclear factor-κB (NF-κB) pathway activation. 
NF-κB, a nuclear transcriptional factor, mediates 
the ALI progression as regulator of different genes 
encoding cytokines, chemokines, adhesion 
molecules and growth factors (Blackwell & 
Christman, 1997; Lawrence et al., 2001; Kalemci et 
al., 2013). 
Moreover, it has been shown that COX-2 
overexpression could be induced by in vitro 
inoculation of LPS on alveolar macrophages 
(Hempel et al., 1994; Uhlig et al., 1996), in 
pulmonary epithelial cells (Mitchell et al., 1994) 
and rat lung tissue (Chida et al., 1994) promoting 
the subsequently acute inflammatory response.  
In the context of these findings, substances 
acting on the NF-kB pathway and on the COX-2 
overexpression could provide an important 
pharmacological benefit, by mitigating the 
inflammatory process involved in ALI.  
As can be observed a significant increase of 
histological markers of lung damage was evidenced 
in our experimental conditions, being an expected 
result according to the reports of other authors 
(Everthart et al., 2006; Kalemci et al., 2013; He et 
al., 2014). Additionally, Dex (20 mg/kg), as 
reference substance, was effective on the analysed 
variables, which confirms the experimental model 
validity. 
Oral administration of D-005 showed 
beneficial effects in mice with LPS-induced ALI. 
D-005 significantly attenuated the presence of 
neutrophil infiltration and also the alveolar 
thickening, which are considered very relevant 
histological evidences of lung tissue injury in ALI 
(Matute-Bello et al., 2011). The minimum effective 
dose was 25 mg/kg since the lower dose tested (5 
mg/kg) produced a slight reduction in HS but it was 
not significant. 
On the other side, a maximum effective 
dose could not be characterized by considering that 
200 mg/kg achieved the highest inhibition on HS, 
but higher doses were not evaluated in this 
experimental protocol. Therefore, further studies 
should elucidate the efficacy of high doses in this 
ALI model. 
Inflammation has been described as an 
important etiologic factor in ALI initiation (Lee et 
al., 2001b; Matute et al., 2008). It is mainly 
associated to a substantial increase of the mediators 
of arachidonic acid synthesis as thromboxane and 
prostaglandins that promote the formation of edema 
and changes in pulmonary perfusion. Indeed, the 
increased synthesis of mediators from COX-2 
causes activation and mast cell degranulation 
releasing proteases and chemokines responsible for 
the increased vascular permeability (PgE2) and 
produces vasodilatation (PgI2), promoting the 
edema formation. Meanwhile, 5-LOX mediators 
promotes chemotaxis and the recruitment of 
macrophages and mast cells to alveolar space 
(LtB4) promoting the inflammatory infiltration 
(Guo et al., 2012). 
ALI/ARDS are characterized by lung 
edema due to increased permeability of the 
alveolar-capillary barrier and subsequent 
impairment of arterial oxygenation. Lung edema, 
endothelial and epithelial injury are accompanied 
by an influx of neutrophils into the interstitium and 
broncheoalveolar space. Hence, activation and 
recruitment of neutrophils are regarded to play a 
key role in progression of ALI/ARDS (Grommes & 
Soehnlein, 2011). For these reasons, the inhibition 
of lung edema and of inflammatory infiltration to 
the lungs constitutes a possible target for those 
drugs with potential benefit for the treatment of 
ALI. 
On this regards, previously in vitro studies 
showed the non-competitive inhibitory effect of D-
005 on COX-2 and 5-LOX activities (Pérez et al., 
2017). Thus, the efficacy of D-005 to reduce LE, 
LW/BW ratio and attenuate the signs of LPS-
induced ALI in mice (neutrophil infiltration and the 
alveolar thickening) could be associated, at least 
partially to both enzymes inhibition.  
On the other hand, it has been demonstrated 
that esterified fatty acids as Methyl palmitate (MP), 
methylester of palmitic acid, attenuate the 
pulmonary histopathological changes in a murine 
model of LPS-mediated ALI and such effects 
involved the inhibition of NF-κB activation 
(Kalemci et al., 2013). Controversially it was 
demonstrated by Lee et al. that saturated fatty acids 
could induce the activation of NF-κB and COX-2 
expression in a murine monocytic cell line (RAW 
264.7). However, a premise discussed in these work 
was the fact that unsaturated fatty acids could not 
only inhibit the saturated fatty acid effect on LPS-
induced NF-κB activation but also the expression of 
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COX-2 and other inflammatory markers (Lee et al., 
2001a).  
Presumably, these findings could clarify 
why D-005 inhibits the activities of COX-2 and 5-
LOX and reduces lung damage in the ALI induced 
by LPS, although the pharmacological mechanism 
to elucidate its effectiveness has not been fully 
elucidated.  
This study constitutes the first report of the 
beneficial effects of D-005 on ALI and establishes 
a fundamental stage to develop new studies and 
provide new evidences about its effects on this 
pathological entity. 
 
CONCLUSIONS 
Pretreatment with single oral doses of D-005 
markedly and significantly prevented the LPS-
induced ALI in mice by reducing not only the 
histological score but also LE and LW/BW ratio. 
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